{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:11Z","timestamp":1777564391781,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to explore the clinical characteristics of perioperative acute gout attacks in patients with varying uric acid levels undergoing orthopedic surgery, identify the risk factors for gout recurrence within the first postoperative year, and provide a disease prevention and diagnostic reference.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This hospital-based retrospective study was conducted between January 2018 and December 2020. According to the blood uric acid levels at admission, the patients were grouped into either the normal uric acid level group or the hyperuricemia group. Patient comorbidities, serum uric acid levels, inflammatory indicators, follow-up recurrence rates, and other indicators were compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>The uric acid decline ratio and the inflammatory indexes (white blood cell count and C-reactive protein level) at the time of the attack were significantly higher in the normal uric acid level group than in the hyperuricemia group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Patients in the hyperuricemia group with diabetes and tophi and those administered diuretics were more prone to acute gout attacks than those in the normal uric acid level group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). In the normal uric acid level group, 22 patients (84.6%) exhibited single joint involvement, whereas only 18 patients (47.4%) in the hyperuricemia group demonstrated single joint involvement (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). After 1\u00a0year of follow-up, the gout recurrence rate in the hyperuricemia group was 44.7%, which was significantly higher that the recurrence rate in the normoglycemic group (11.5%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Presenting tophi in perioperative orthopedic surgery patients was found to be an independent risk factor for gout recurrence within 1\u00a0year (RR\u2009=\u20094.80; <jats:italic>P<\/jats:italic>\u2009=\u20090.029).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The recurrence rate of gout in patients with hyperuricemia during perioperative period increased 1\u00a0year after operation. Therefore, it is crucial to monitor the uric acid level to prevent acute gout attacks during the perioperative period and recurrence during the 1-year follow-up period. Moreover, the risk of an acute gout recurrence 1\u00a0year after operation increased in patients who presented tophi; therefore, it is necessary to maintain appropriate blood uric acid level during perioperative period among patients undergoing orthopedic surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-023-03536-8","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T03:02:51Z","timestamp":1674442971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Acute gout attacks during the perioperative period and risk factors of recurrence after orthopedic surgery among untreated gout patients"],"prefix":"10.1186","volume":"18","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"10287","key":"3536_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843\u201355.","journal-title":"Lancet"},{"issue":"11","key":"3536_CR2","first-page":"2403","volume":"29","author":"E Arromdee","year":"2002","unstructured":"Arromdee E, Michet CJ, Crowson CS, O\u2019Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising. J Rheumatol. 2002;29(11):2403\u20136.","journal-title":"J Rheumatol"},{"issue":"9","key":"3536_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/ard.2007.078683","volume":"67","author":"EH Kang","year":"2008","unstructured":"Kang EH, Lee EY, Lee YJ, Song YW, Lee EB. Clinical features and risk factors of postsurgical gout. Ann Rheum Dis. 2008;67(9):1271\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3536_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1136\/annrheumdis-2011-201215","volume":"71","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Chen C, Choi H, et al. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis. 2012;71(9):1448\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3536_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.amjmed.2013.06.026","volume":"126","author":"M Dubreuil","year":"2013","unstructured":"Dubreuil M, Neogi T, Chen CA, et al. Increased risk of recurrent gout attacks with hospitalization. Am J Med. 2013;126(12):1138-41.e1.","journal-title":"Am J Med"},{"issue":"7","key":"3536_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1445-2197.2006.03786.x","volume":"76","author":"LB Oldmeadow","year":"2006","unstructured":"Oldmeadow LB, Edwards ER, Kimmel LA, Kipen E, Robertson VJ, Bailey MJ. No rest for the wounded: early ambulation after hip surgery accelerates recovery. ANZ J Surg. 2006;76(7):607\u201311.","journal-title":"ANZ J Surg"},{"issue":"5","key":"3536_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/rheumatology\/keq363","volume":"50","author":"D Rothenbacher","year":"2011","unstructured":"Rothenbacher D, Primatesta P, Ferreira A, Cea-Soriano L, Rodr\u00edguez LA. Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology (Oxford). 2011;50(5):973\u201381.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3536_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/biom11020280","volume":"11","author":"WZ Zhang","year":"2021","unstructured":"Zhang WZ. Why does hyperuricemia not necessarily induce gout. Biomolecules. 2021;11(2):280.","journal-title":"Biomolecules"},{"issue":"2","key":"3536_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","volume":"26","author":"T Bardin","year":"2014","unstructured":"Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26(2):186\u201391.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"3536_CR10","first-page":"1501","volume":"27","author":"KC Lin","year":"2000","unstructured":"Lin KC, Lin HY, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol. 2000;27(6):1501\u20135.","journal-title":"J Rheumatol"},{"issue":"10","key":"3536_CR11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, et al. 2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789\u201398.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3536_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13075-020-02173-4","volume":"22","author":"S Li","year":"2020","unstructured":"Li S, Cui L, Cheng J, et al. Repeated measurements of serum urate and mortality: a prospective cohort study of 152,358 individuals over 8 years of follow-up. Arthritis Res Ther. 2020;22(1):84.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3536_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.intimp.2005.11.011","volume":"6","author":"JM Viveros-Paredes","year":"2006","unstructured":"Viveros-Paredes JM, Puebla-P\u00e9rez AM, Guti\u00e9rrez-Coronado O, Sandoval-Ram\u00edrez L, Villase\u00f1or-Garc\u00eda MM. Dysregulation of the Th1\/Th2 cytokine profile is associated with immunosuppression induced by hypothalamic-pituitary-adrenal axis activation in mice. Int Immunopharmacol. 2006;6(5):774\u201381.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3536_CR14","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1038\/s41598-018-26276-w","volume":"8","author":"S Liang","year":"2018","unstructured":"Liang S, Zhang D, Qi J, Song X, Xue J. Reduced peak stimulated growth hormone is associated with hyperuricemia in obese children and adolescents. Sci Rep. 2018;8(1):7931.","journal-title":"Sci Rep"},{"issue":"6","key":"3536_CR15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/ATVBAHA.117.309128","volume":"37","author":"R Spiga","year":"2017","unstructured":"Spiga R, Marini MA, Mancuso E, et al. Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-\u03baB signaling pathway in HepG2 cells. Arterioscler Thromb Vasc Biol. 2017;37(6):1241\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3536_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000443435","volume":"41","author":"X Li","year":"2016","unstructured":"Li X, Xiang X, Hu J, et al. Association between serum cortisol and chronic kidney disease in patients with essential hypertension. Kidney Blood Press Res. 2016;41(4):384\u201391.","journal-title":"Kidney Blood Press Res"},{"issue":"12","key":"3536_CR17","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/art.41038","volume":"71","author":"A Chhana","year":"2019","unstructured":"Chhana A, Pool B, Wei Y, et al. Human cartilage homogenates influence the crystallization of monosodium urate and inflammatory response to monosodium urate crystals: a potential link between osteoarthritis and gout. Arthritis Rheumatol. 2019;71(12):2090\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"3536_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.27421","volume":"3","author":"N McCormick","year":"2020","unstructured":"McCormick N, Rai SK, Lu N, Yokose C, Curhan GC, Choi HK. Estimation of primary prevention of gout in men through modification of obesity and other key lifestyle factors. JAMA Netw Open. 2020;3(11): e2027421.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"3536_CR19","first-page":"299","volume":"45","author":"PC Robinson","year":"2016","unstructured":"Robinson PC, Stamp LK. The management of gout: much has changed. Aust Fam Phys. 2016;45(5):299\u2013302.","journal-title":"Aust Fam Phys"},{"issue":"11","key":"3536_CR20","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/annrheumdis-2017-211472","volume":"76","author":"SM Nielsen","year":"2017","unstructured":"Nielsen SM, Bartels EM, Henriksen M, et al. Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis. 2017;76(11):1870\u201382.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3536_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/annrheumdis-2016-209958","volume":"76","author":"C Maglio","year":"2017","unstructured":"Maglio C, Peltonen M, Neovius M, et al. Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial. Ann Rheum Dis. 2017;76(4):688\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3536_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00393-011-0953-9","volume":"71","author":"AK Tausche","year":"2012","unstructured":"Tausche AK, Manger B, M\u00fcller-Ladner U, Schmidt B. Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia. Z Rheumatol. 2012;71(3):224\u201330.","journal-title":"Z Rheumatol"},{"issue":"10","key":"3536_CR23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1312\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3536_CR24","first-page":"ii9","volume":"48","author":"F Perez-Ruiz","year":"2009","unstructured":"Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology (Oxford). 2009;48(2):ii9\u201314.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3536_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/RHU.0b013e3181945d2c","volume":"15","author":"R Halpern","year":"2009","unstructured":"Halpern R, Fuldeore MJ, Mody RR, Patel PA, Mikuls TR. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol. 2009;15(1):3\u20137.","journal-title":"J Clin Rheumatol"},{"issue":"7","key":"3536_CR26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005. Ann Rheum Dis. 2008;67(7):960\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3536_CR27","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/acr.22855","volume":"68","author":"A Abhishek","year":"2016","unstructured":"Abhishek A, Valdes AM, Zhang W, Doherty M. Association of serum uric acid and disease duration with frequent gout attacks: a case-control study. Arthritis Care Res (Hoboken). 2016;68(10):1573\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11\u201312","key":"3536_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00508-010-1384-3","volume":"122","author":"SK Fokter","year":"2010","unstructured":"Fokter SK, Repse-Fokter A. Acute gouty arthritis in a patient after total knee arthroplasty. Wien Klin Wochenschr. 2010;122(11\u201312):366\u20137.","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"3536_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.7547\/17-097","volume":"109","author":"L Dang","year":"2019","unstructured":"Dang L, Kim JK, Lee KB. Crystal-induced arthritis after total ankle arthroplasty. J Am Podiatr Med Assoc. 2019;109(2):159\u201361.","journal-title":"J Am Podiatr Med Assoc"},{"key":"3536_CR30","doi-asserted-by":"crossref","first-page":"232470961986499","DOI":"10.1177\/2324709619864990","volume":"7","author":"B Sanders","year":"2019","unstructured":"Sanders B, Abdulfatah M, Aljuaid M, Tawhari I. Polyarticular septic arthritis due to non-typeable haemophilus influenzae with concomitant new-onset acute gouty arthritis. J Investig Med High Impact Case Rep. 2019;7:2324709619864990.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"9","key":"3536_CR31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/rheumatology\/keg297","volume":"42","author":"KH Yu","year":"2003","unstructured":"Yu KH, Luo SF, Liou LB, et al. Concomitant septic and gouty arthritis\u2013an analysis of 30 cases. Rheumatology (Oxford). 2003;42(9):1062\u20136.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-03536-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T03:04:37Z","timestamp":1674443077000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-03536-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3536"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-03536-8","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All investigations were approved by the ethic committee of the 900th Hospital of the Joint Logistics Team, PLA (No. 2022-017 on July 8, 2022), and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}